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ABSTRACT 
 
Background: The pathophysiology of ischemic stroke is closely related to the inflammatory response that directly 
proportional to brain tissue damage. Interleukin-10 (IL-10) is an important anti-inflammatory cytokine that arises in 
response to brain injury.  
Aim: To determine the association of serum IL-10 levels with clinical outcomes of acute ischemic stroke patients.  
Method: An analytical observational study with prospective cohort designs included 48 subjects of first acute 
ischemic stroke. On 3rd and 21stday of onset, scores of national institutes of health stroke scale (NIHSS) were 
assessed and venous blood was taken to measure IL-10 serum levels.  
Result: Among 48 subjects, 32 (66.67%) subjects had high IL-10 serum level and 16 (33.3%) had normal level. 
There were no significant relationships between age (p=1.000), sex (p=0.833), type of lesion (p=0.683), ECG 
(p=0.230), nutritional status (p=0.186), hypertension (p=0.215), diabetes mellitus (p=0.130), dyslipidemia 
(p=0.383), smoking status (p=0.654) and NIHSS score.The multivariate analysis obtained significant correlation  
between interleukin (IL)-10 (p=0.023, OR=5.456), location of non-dominant hemispheric lesions (p=0.024, 
OR=5.090) with NIHSS score changes. 
Conclusion: There was significant association between IL-10 serum levels, location of  non dominant 
hemispheric lesion andan improvement of clinical outcomes of acute ischemic stroke patients. 
Keywords: Interleukin-10 serum levels,acute ischemicstroke;clinical outcomes of acute ischemic stroke patients 
 
INTRODUCTION 
 
Stroke is the third leading cause of death worldwide, as 
well as being a major cause of disability especially in 
developing countries.1  The occurrence of ischemic stroke 
is more common than hemorrhage strokes, approximately 
80-85% of all stroke events.2 The pathophysiology of 
ischemic stroke is thought to be related to the inflammatory 
response. Interleukin-10 (IL-10) is an important anti-
inflammatory cytokine that arises in response to brain 
injury. IL-10 facilitates the resolution of inflammatory 
cascades, which, when prolonged, leads to secondary 
brain damage.3 The role of  IL-10 in clinical outcomes of 
ischemic stroke is controversial. Some evidence suggests 
that cerebral IL-10 expression is useful in post stroke, since 
IL-10 overexpressing IL-10 transgenic mice on astrocytes, 
microglia, and endothelial brain cells indicate a smaller 
infarction.4The aim of this study is to prove the relationship 
between immunological response and clinical outcomes of 
an acute ischemic stroke patient. The immunological 
response was seen from the peripheral circulating IL-10 
levels, whereas the clinical outputs of ischemic stroke was 
measured by NIHSS score. 
 
MATERIALS AND METHODS 
 
The research was an analytical observational study with 
prospective cohort designsconducted in dr. Kariadi and dr 
Soesilo hospital both inpatient and outpatient units. The 
subjects were acute ischemic stroke patients with first 
onset <72 hours proven by a CT scan of the plain head and 
agreed to participate. The patients who had an infection 
when admitted, had ischemic stroke with malignancy, had a 
history of moderate / severe head injury <3 monthsand an 
acute myocardial infarction 3 weeks before onset of stroke, 
hadpsychiatric disorders, had done rTPa, were pregnant, 
and had a historytaking of steroid or immunosuppressant 
drugs, wereexcluded from this study. Patients who died 
before 21st day of onset, developed an infection or being 
discharged between 3rd and 21st day of onset were dropped 
out of this study. 
The subjects were then measured the NIHSS scores 
and taken their venous blood sampleson the 3rd day onset 
of ischemic stroke as many as 5 cc of frozen blood without 
EDTA to check serum IL-10 levels. During treatment, the 
subjects obtained standard stroke therapy such as anti-
platelet, anti-hypertension, and neurotropic. After 21st day 
onset, patients were remeasured NIHSS score.  
Statistical Analysis: Statistical analysis included 
descriptive, bivariate and multivariateanalysis. Descriptive 
analysis describedthe characteristics of the subjects. Chi-
square and fisher exact test were used to test the 
relationship between variables  while multiple regression 
logistic test was used to know the contribution of 
confounding variables. The p value was considered 
significant if p <0.05. 
Research Ethics: Prior to the research, the authors 
applied for ethical clearance from the Medical Research 
Ethics Committee, Faculty of Medicine,Diponegoro 
University / dr.Kariadi hospital. Family approvals were 
requested in the form of written informed consent. Patients 
or families had the right to refuse to be included in the 
study without any consequences. The identities of the 
patient were kept confidential. 
 
RESULT 
 
This study recruited 48 subjects who met inclusion and 
exclusion criteria. Table 1 shows the characteristics of 
subjects. The majority of respondents were male 
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(28;58.3%), adult (37;77.1%), normoweight (46;95.8%), 
having normosinus rhythm (34;70.8%), no smoking 
(38;79.2%), dyslipidemia (24;50%), did not have diabetes 
mellitus (35;72.9%); having hypertension (41;85.4%), 
having non dominant hemispheric lesion (27;56.2%), and 
had lacunar lesion type (42;87.5%). The result showed that 
32 (66.7%) subjects had high IL-10 serum levelsand 16 
(33.3%) subjects had normal IL-10 serum levels. On the 
other hand, 27(56.2%) subjects had improved NIHSS while 
21 subjects had fixed NIHSS score (43.8%) as can be seen 
in table 2. 
Bivariate analyses showed that age (p=1.000), sex 
(p=0.833), type of lesion (p=0.683), ECG (p=0.230), 
nutritional status (p=0.186), hypertension (p=0.215), 
diabetes mellitus (p=0.130), dyslipidemia (p=0.383) and 
smoking status (p=0.654) were not significantly correlated 
with the NIHSS score. However, there was a significant 
correlation between the location of ischemic (p=0.025), IL-
10 levels(p=0.014) and NIHSS score changes.(Table 3) 
Multivariate analysis obtainedinsignificant correlation 
between hypertension (p=0.133; OR=0.218), diabetes 
mellitus (p=0.920; OR=3.913) and NIHSS score  while 
interleukin-10 level  (p=0.023, OR=5.456) and location of 
non-dominant hemispheric lesion (p=0.024, OR=5.090) had 
significant correlation with NIHSS score changes.(Table 3)
 
Table 1:  Statistical Analytic of Confounding Variables 
Subject Characteristics 
NIHSS Changes 
Statistical 
Analysis 
P Improve Fixed 
N % n % 
Gender 
 Man 16 59.3 12 57.1 X2=0.022 0.883§ 
 Woman 11 40.7 9 42.9   
Age 
 Elderly 6 22.2 5 23.8 X2=0.017 1.000¥ 
 Adult 21 77.8 16 76.2   
BMI 
 Non obesity 27 100 19 90.5 X2=2.683 0.186¥ 
 Obesity 0 0 2 9.5   
ECG 
 NSR 21 77.8 13 61.9 X2=1.441 0.230§ 
 LVH    6 22.2 8 38.1   
Location of Ischemic 
      Non dominant Hemisphere  19 70.4 8 38.1 X2=5.000 0.025§* 
     Dominant Hemisphere 8 29.6 13 61.9   
Type of Lesion 
 Single territorial 4 14.8 2 9.5 X2=0.302 0.683¥ 
 Lacunar 23 85.2 19 90.5   
DM 
 Yes 5 18.5 8 38.1 X2=2.292 0.130§ 
 No 22 81.5 13 61.9   
Dyslipidemia 
 Yes 12 44.4 12 57.1 X2=0.762 0.383§ 
 No 15 55.6 9 42.9   
Hypertension 
     Yes 25 92.6 16 76.2 X2=2.551 0.215¥ 
      No 2 7.4 5 23.8   
Smoking status 
 Yes 5 18.5 5 23.8 X2=0.210 0.654§ 
 No 22 81.5 16 76.2   
Abreviation : * Significant; ¥ Fisher’s Exact; § Pearson chi square; 
 
Table 2: Chi-Square Test between  IL-10 serum levels with NIHSS score changes 
IL-10 serum levels 
NIHSS score changes 
P Improve Fixed 
N % N % 
High 22 81.8 10 47.6 0.014§ 
Normal 5 18.5 11 52.4  
Abreviation : § Pearson chi square 
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Table 3: Multivariate Analysis by using Logistic Regression 
 
DISCUSSION 
 
The pathophysiology of ischemic stroke involves a complex 
inflammatory response, ranging from the process of 
thrombosis or embolism that causes the death of neuronal 
cells in the brain parenchyma.1 Neuronal death is caused 
by an ischemic cascade consisting of glutamate exotoxicity, 
intracellular calcium overload, free radical toxicity, and  
inflammation of cerebral parenchyma5. The inflammatory 
response to ischemic stroke begins from a process of 
atherosclerosis before the onset of stroke.6Cytokines 
become the medium of communication between immune 
cells in activating or suppressing inflammatory responses. 
Proinflammatory cytokines such as IL-1β, TNF-α, and anti-
inflammatory cytokines are IL-10, TGF-β.4,7-9 
Interleukin-10 (IL-10) is an important anti-
inflammatory cytokine expressed in response to brain 
injury, where it facilitates the resolution of inflammatory 
cascades, which if prolonged causes secondary brain 
damage.3It has been estimated that elevated levels of IL-10 
have neuroprotective function. Higher levels of IL-10 serum 
suggest a tissue after an ischemic stroke. In addition, the 
number of peripheral blood mononuclear cells (PBMC) that 
secrete IL-10 increases in patients with ischemic stroke 
and cerebral hemorrhage.10Previous study, found a 
significant correlation between IL-10 expression levels and 
neurological improvement.11In our study, we found a 
significant correlation between IL-10 serum levels and 
NIHSS score changes. It had inverted correlation, higher 
IL-10 serum levels had more improvement to clinical 
outcomes of ischemic stroke. IL-10 provides a negative 
feedback mechanism by blocking the monocytes/ 
macrophage gene transcription to limit the production of 
proinflammatory cytokines, IL-6 and TNF-a, intercellular 
adhesion molecule-1 (ICAM-1), and matrix 
metalloproteinase (MMP)11. 
Previous research on side of lesion has yielded 
contradictory results. Despite reviews that found no 
differences in outcome between dominant and non 
dominant cerebral lesions.12Our study supports findings 
obtained by other researchers who found significant 
correlation between location of lesion with NIHSS score 
changes. Non dominant hemispheric lesion had more 
improvement in clinical outcome of ischemic stroke 
patients. However, it was mentioned that infarct lesions in 
dominant hemispheres tend to produce worse clinical 
outcomes, as well as a heavier degree of stroke.13In this 
study, majority patient used left hemisphere as their 
dominant hemisphere. Based on previous study, on right 
hemisphere they identified the parietal lobe and putamen 
as key areas associated with unfavorable outcomes. The 
right parietal lobe is a complex structure with a rich array of 
functions including the primary somatosensory cortex 
(postcentral gyrus), as well as areas critical for 
somatosensory association and visuospatial function. The 
putamen is part of the striatum with important cortical and 
sub-cortical connections that predominantly mediate motor 
function14. 
In the left hemisphere, the primary areas of 
importance identified in the tree were the uncinate 
fasciculus, precuneus, and angular gyrus. The uncinate 
fasciculus connects the orbitofrontal and anterior temporal 
cortex and is traditionally understood to be a limbic 
structure with proposed functions including episodic 
Variable NIHSS Changes Bivariate Multivariate 
Improve Fixed p value OR CI 95 p 
value 
OR(EXP(
B)) 
CI 95 
N N Min max Min max 
Gender 
Man 
Woman 
 
16 
11 
 
12 
9 
 
0.89 
 
 
1.09 
 
0.34 
 
3.47 
    
BMI 
Non obesity 
Obesity 
 
0 
27 
 
2 
19 
 
0.19 
 
0.42 
 
0.29 
 
0.54 
    
ECG 
NSR 
LVH 
 
21 
6 
 
13 
8 
 
0.23 
 
0.47 
 
0.13 
 
1.64 
 
0.125 
 
3.60 
 
0.70 
 
18,51 
Hypertension 
Yes  
No 
 
25 
2 
 
16 
5 
 
0.22 
 
0.26 
 
0.04 
 
1.48 
 
0.133 
 
0.22 
 
0.03 
 
1.59 
Type of Lesion 
Single Territorial  
Lacunar 
 
4 
23 
 
2 
19 
 
0.68 
 
0.61 
 
0.10 
 
3.67 
    
Ischemic location 
Non dominant 
Hemisphere  
Dominant Hemisphere 
 
 
19 
8 
 
 
8 
13 
 
 
0.03 
 
 
3.86 
 
 
1.15 
 
 
12.9 
 
 
0.024 
 
 
5.09 
 
 
1.24 
 
 
20.93 
DM 
Yes 
No 
 
5 
22 
 
8 
13 
 
0.13 
 
2.71 
 
0.73 
 
10.1 
 
0.92 
 
3.91 
 
0.80 
 
19.12 
Dyslipidemia 
Yes 
No 
 
12 
15 
 
12 
9 
 
0.38 
 
1.68 
 
0.53 
 
5.27 
    
IL-10 serum levels 
High 
Normal 
 
22 
5 
 
10 
11 
 
 
0.03 
 
 
4.84 
 
1.33 
 
17.7 
 
0.02 
 
5.46 
 
1.27 
 
 
23.53 
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memory, language (left-hemisphere), and social and 
emotional processing.15,16The precuneus is a medial 
parietal structure that has extensive cortical and sub-
cortical interconnections and has been implicated in a 
range of higher order functions including consciousness, 
visuospatial imagery, episodic memory retrieval, and self-
processing.17 It has been identified as one of the primary 
brain areas demonstrating task-independent decreases in 
activation on functional imaging and is one of the most 
metabolically active brain regions during rest, being one of 
the principal components of the default-mode network.18 
The left angular gyrus, along with Wernicke’s area (part of 
the superior temporal gyrus), the supramarginalgyrus, and 
parts of the middle temporal gyrus, form the posterior 
language area. It has important roles in language 
comprehension and arithmetic retrieval.14,19Specific infarct 
patterns are related to cerebral arterial occlusion 
mechanisms and are correlated with functional outcome. 
Otherwise, the results of a study indicates that infarct 
patterns on diffuse weighted imaging (DWI) might be a clue 
for determining ischemic stroke etiology on patients with 
major cerebral artery occlusion. In this study we found 
insignificant correlation between type of lesion (lacunar 
lesion and territorial lesion) with clinical outcomes. The 
degree of stroke severity is determined by the extent of the 
lesion, where the lacunar lesion is milder clinically 
compared to the territorial type, and these findings are 
consistent with several studies that suggest lacunar infarcts 
are most commonly found in either solitary or multiple.5 
Previous study showed that gender factors did not 
affect the clinical outcome of acute ischemic stroke. This 
study also had insignificant correlation between gender and 
improvement of NIHSS score changes. Some authors have 
shown that increased age predicts poor outcome after 
stroke.20In this study, we did not notice this correlation 
between age and NIHSS changes, however we found 
insignificant correlation that same as other researchers 
which maintain that age is not an independent predictor of 
functional outcome.21 Some studies suggest that 
hypertension is a risk factor for ischemic stroke. In this 
study there was no association between hypertension and 
the NIHSS score because hypertension is not the only 
independent predictor of clinical outcomes of ischemic 
stroke. Comorbid medical disorders (hypertension, 
diabetes, cardiac disease) were not found to be 
significantly related to functional outcome.1Wealso found 
hypertension, diabetic mellitus, past medical history, 
electrocardiography examination did not correlate to clinical 
outcomes of acute ischemic stroke. 
Several modifiable and non-modifiable factors such 
as smoking, hyperlipidemia, obesity, sedentary lifestyle, 
cardiac abnormalities (e.g. arterial fibrillation), age, and sex 
have been reported to increase the risk of acute ischemic 
stroke (AIS).22Dyslipidemia is a major risk factor for 
coronary heart disease (CHD) and its role in the 
pathogenesis of ischemic stroke is still unclear.23Serum 
levels of TC, LDL-C, and HDL-C are positively related with 
the outcome in patients with acute ischemic stroke.24This 
study showed insignificant correlation between body mass 
index (BMI), dyslipidemia, and smoking status. This is 
probably due to the lack of specific categories in this study.  
 
CONCLUSION 
 
The finding concluded that there was a significant 
association between IL-10 serum levels and location of 
non-dominant hemispheric lesion with clinical outcome 
improvement of acute ischemic stroke patients. 
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